Siemens Healthineers (NYSE:SI) said today that its Atellica Solution won CE Mark and that the advanced diagnostic system is now available in Europe, the U.S., South America and Asia.
The system consists of scalable immunoassay and chemistry analyzers, the company said, and can operate as a stand-alone system or connect to Aptio Automation.
Get the full story at our sister site, Drug Delivery Business News.